SEC Form 4 · accession 0001178913-26-004095
Evogene Ltd. · EVGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leon Recanati
Director
Period of report
Aug 11, 2026
Accepted (ET)
Aug 13, 2026 · 7:00 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001574565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 11, 2026 | P | 460,000 | $0.635 | A | 1,343,886 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $54.32 | holding | — | — | — | Jun 11, 2021 | May 16, 2027 | Ordinary Shares | 250 | 250 | D |
| Stock Option (right to buy)F1 | $32.05 | holding | — | — | — | Jun 11, 2022 | Jun 25, 2028 | Ordinary Shares | 250 | 250 | D |
| Stock Option (right to buy)F1 | $17.68 | holding | — | — | — | Jun 11, 2023 | Jul 30, 2029 | Ordinary Shares | 250 | 250 | D |
| Stock Option (right to buy)F1 | $12.03 | holding | — | — | — | Jun 11, 2024 | Nov 17, 2030 | Ordinary Shares | 250 | 250 | D |
| Stock Option (right to buy)F1 | $39.32 | holding | — | — | — | Jun 11, 2025 | Jun 11, 2031 | Ordinary Shares | 250 | 250 | D |
| Stock Option (right to buy)F1 | $28.62 | holding | — | — | — | Aug 10, 2022 | Sep 1, 2031 | Ordinary Shares | 1,800 | 1,800 | D |
| Stock Option (right to buy)F1 | $10.50 | holding | — | — | — | Sep 15, 2023 | Sep 15, 2032 | Ordinary Shares | 1,800 | 1,800 | D |
| Stock Option (right to buy)F1 | $6.03 | holding | — | — | — | May 11, 2024 | May 11, 2033 | Ordinary Shares | 1,800 | 1,800 | D |
| Stock Option (right to buy)F1 | $7.16 | holding | — | — | — | Jun 13, 2025 | Jun 13, 2034 | Ordinary Shares | 1,800 | 1,800 | D |
| Stock Option (right to buy)F1,F2 | $1.29 | holding | — | — | — | — | Aug 18, 2035 | Ordinary Shares | 2,500 | 2,500 | D |
Explanation of responses
- F1There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F2The options reported in this row vest equally on a quarterly basis (25% per quarter) such that they will be fully vested by the one-year anniversary of the August 18, 2025 grant date.
Remarks
Exhibit 24.1 - Power of Attorney.